This position paper provides specific insights for those who want to anticipate the global pharma market evolution over the 2019-2024 period, while considering the impact of the Covid-19
News
With 3 million people affected in France, rare diseases are a major public health issue. 25% of...
This position paper covers the following key issues:
French health authorities intent – cautiously – to facilitate the development of the biosimilars market by: This...